
Paul D Mahoney MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Interventional Cardiology and Structural Heart Disease
Join to view full profile
755 E McDowell RdFloor 4Phoenix, AZ 85006
Phone+1 602-521-3118
Fax+1 602-521-3661
Dr. Mahoney is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Mahoney is a cardiologist based in Phoenix, AZ specializing in Structural and Interventional Cardiology. He is Professor of Medicine, Director of Transcatheter Valve Therapies at Banner University Medicine Heart Institute in Phoenix.
Education & Training
University of Pennsylvania Health SystemFellowship, Interventional Cardiology, 1999 - 2000
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 1996 - 1999
University of Pennsylvania Health SystemResidency, Internal Medicine, 1993 - 1996
Weill Cornell MedicineClass of 1993
Certifications & Licensure
AZ State Medical License 2026 - 2028
HI State Medical License 2023 - 2028
NC State Medical License 2024 - 2027
PA State Medical License 2023 - 2026
VA State Medical License 1999 - 2026
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- ABSORB III Randomized Controlled Trial (RCT)
Publications & Presentations
PubMed
- Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Optimize PRO Study.Danny Dvir, Hasan A Jilaihawi, Douglas Fraser, Josep Rodés-Cabau, Tamim Nazif
JACC. Cardiovascular Interventions. 2026-08-10 - Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial.Gregory P Fontana, Ron Waksman, Arash Salemi, Marc Cohen, William Abernethy
Eurointervention. 2026-07-06 - Giant Coronary Artery Aneurysm Arising From a Septal Perforator: Diagnosis and Percutaneous Management.Mariam Dvalishvili, Ahmed Ghoneem, Constantine Marcu, Paul Mahoney
JACC. Case Reports. 2026-07-01
Lectures
- Transcatheter Aortic Valve Replacement and How I Treated My PatientCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
- Complication ManagementCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
- Interpretation of Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-MakingCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Press Mentions
ECU Health Medical Center Offers New Treatments for Tricuspid Valve RegurgitationApril 24th, 2025
Know Your Options: What Cardiologists Recommend When Alternative Access Is Required for TAVRFebruary 25th, 2025
Expert Consensus Released by SCAI on Alternative Access Techniques for Transaortic Valve Replacement (TAVR)February 25th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









